This paper is in the following e-collection/theme issue:

Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1041) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1641) Infodemiology and Infoveillance (1349) Pharmacovigilance (134) Infoveillance and Social Listening (209)

Published on in Vol 3, No 1 (2017): Jan-Mar

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis

Authors of this article:

Laurie S. Anderson1 Author Orcid Image ;   Heidi G Bell2 Author Orcid Image ;   Michael Gilbert3 Author Orcid Image ;   Julie E Davidson4 Author Orcid Image ;   Christina Winter4 Author Orcid Image ;   Monica J Barratt5, 6, 7 Author Orcid Image ;   Beta Win4 Author Orcid Image ;   Jeffery L Painter1 Author Orcid Image ;   Christopher Menone3 Author Orcid Image ;   Jonathan Sayegh7 Author Orcid Image ;   Nabarun Dasgupta3 Author Orcid Image
Article Authors Cited by (36) Tweetations (13) Metrics

Journals

  1. Sarker A, DeRoos A, Perrone J. Mining social media for prescription medication abuse monitoring: a review and proposal for a data-centric framework. Journal of the American Medical Informatics Association 2020;27(2):315 View
  2. Smart R, Kase C, Taylor E, Lumsden S, Smith S, Stein B. Strengths and weaknesses of existing data sources to support research to address the opioids crisis. Preventive Medicine Reports 2020;17:101015 View
  3. Bousquet C, Dahamna B, Guillemin-Lanne S, Darmoni S, Faviez C, Huot C, Katsahian S, Leroux V, Pereira S, Richard C, Schück S, Souvignet J, Lillo-Le Louët A, Texier N. The Adverse Drug Reactions from Patient Reports in Social Media Project: Five Major Challenges to Overcome to Operationalize Analysis and Efficiently Support Pharmacovigilance Process. JMIR Research Protocols 2017;6(9):e179 View
  4. Meacham M, Roh S, Chang J, Ramo D. Frequently asked questions about dabbing concentrates in online cannabis community discussion forums. International Journal of Drug Policy 2019;74:11 View
  5. Taylor J, Pagliari C. Mining social media data: How are research sponsors and researchers addressing the ethical challenges?. Research Ethics 2018;14(2):1 View
  6. Keller M, Mosadeghi S, Cohen E, Kwan J, Spiegel B. Reproductive Health and Medication Concerns for Patients With Inflammatory Bowel Disease: Thematic and Quantitative Analysis Using Social Listening. Journal of Medical Internet Research 2018;20(6):e206 View
  7. Audeh B, Calvier F, Bellet F, Beyens M, Pariente A, Lillo-Le Louet A, Bousquet C. Pharmacology and social media: Potentials and biases of web forums for drug mention analysis—case study of France. Health Informatics Journal 2020;26(2):1253 View
  8. Chen X, Faviez C, Schuck S, Lillo-Le-Louët A, Texier N, Dahamna B, Huot C, Foulquié P, Pereira S, Leroux V, Karapetiantz P, Guenegou-Arnoux A, Katsahian S, Bousquet C, Burgun A. Mining Patients' Narratives in Social Media for Pharmacovigilance: Adverse Effects and Misuse of Methylphenidate. Frontiers in Pharmacology 2018;9 View
  9. van Stekelenborg J, Ellenius J, Maskell S, Bergvall T, Caster O, Dasgupta N, Dietrich J, Gama S, Lewis D, Newbould V, Brosch S, Pierce C, Powell G, Ptaszyńska-Neophytou A, Wiśniewski A, Tregunno P, Norén G, Pirmohamed M. Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. Drug Safety 2019;42(12):1393 View
  10. Daniulaityte R, Lamy F, Barratt M, Nahhas R, Martins S, Boyer E, Sheth A, Carlson R. Characterizing marijuana concentrate users: A web-based survey. Drug and Alcohol Dependence 2017;178:399 View
  11. Schifano F, Chiappini S. Is There a Potential of Misuse for Venlafaxine and Bupropion?. Frontiers in Pharmacology 2018;9 View
  12. Iliou T, Casta P, Lequeux J, Pochard L, Frauger E, Spadari M, Micallef J. Venlafaxine Abuse in a Patient With a History of Methylphenidate Abuse. Journal of Clinical Psychopharmacology 2019;39(2):172 View
  13. Schifano F, Chiappini S, Corkery J, Guirguis A. Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. Brain Sciences 2018;8(4):73 View
  14. Wang D, Su J, Yu H. Feature Extraction and Analysis of Natural Language Processing for Deep Learning English Language. IEEE Access 2020;8:46335 View
  15. O'Connor K, Sarker A, Perrone J, Gonzalez Hernandez G. Promoting Reproducible Research for Characterizing Nonmedical Use of Medications Through Data Annotation: Description of a Twitter Corpus and Guidelines. Journal of Medical Internet Research 2020;22(2):e15861 View
  16. Kim S, Marsch L, Hancock J, Das A. Scaling Up Research on Drug Abuse and Addiction Through Social Media Big Data. Journal of Medical Internet Research 2017;19(10):e353 View
  17. Caster O, Dietrich J, Kürzinger M, Lerch M, Maskell S, Norén G, Tcherny-Lessenot S, Vroman B, Wisniewski A, van Stekelenborg J. Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. Drug Safety 2018;41(12):1355 View
  18. Comfort S, Perera S, Hudson Z, Dorrell D, Meireis S, Nagarajan M, Ramakrishnan C, Fine J. Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. Drug Safety 2018;41(6):579 View
  19. Audeh B, Bellet F, Beyens M, Lillo-Le Louët A, Bousquet C. Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project. Drug Safety 2020;43(9):835 View
  20. Wolffsohn J, Leteneux-Pantais C, Chiva-Razavi S, Bentley S, Johnson C, Findley A, Tolley C, Arbuckle R, Kommineni J, Tyagi N. Social Media Listening to Understand the Lived Experience of Presbyopia: Systematic Search and Content Analysis Study. Journal of Medical Internet Research 2020;22(9):e18306 View
  21. Lucas B, Landman T. Social listening, modern slavery, and COVID-19. Journal of Risk Research 2021;24(3-4):314 View
  22. Zullig K, Divin A. Quantifying Healthy Days Lost to the Non-Medical Use of Prescription Drugs (NMUPD) among a Sample of College Students. Applied Research in Quality of Life 2022;17(2):655 View
  23. Stagi L, Bocchi I, Bianco S, Sirizzotti G, Bernardini D, Calderazzo V, Pirisino G, Grisoni I, Romano S. Pharmacovigilance and the digital world in Italy: presentation of the results of a national survey. Therapeutic Advances in Drug Safety 2021;12 View
  24. Debeltz B. Educational Intervention for Bupropion Abuse Prevention. Journal of Doctoral Nursing Practice 2021;14(1):34 View
  25. Wightman R, Erowid E, Erowid F, Thyssen S, Wheeler M, Pulminskas B, Olson R, Green T. Confirmed reports of bupropion sold as crack cocaine in the illicit drug supply. Clinical Toxicology 2021;59(11):1031 View
  26. Richey P, Laageide L, Swick B. Stimulant use in patients presenting with psychocutaneous disorders. Journal of the American Academy of Dermatology 2022;86(5):1002 View
  27. Mazel S, Zisman-Ilani Y, Hennig S, Garnick D, Nicholson J. Virtual Engagement in a Social Media Community of Mothers With Substance Use Disorders: Content Analysis. JMIR Formative Research 2021;5(6):e24353 View
  28. Feng X, Bi Y, Wang J, Li T, Yu G, Zhang T, Xu H, Zhang C, Sun Y. Discovery of the Potential Novel Pharmacodynamic Substances From Zhi-Zi-Hou-Po Decoction Based on the Concept of Co-Decoction Reaction and Analysis Strategy. Frontiers in Pharmacology 2022;12 View
  29. Lohiniva A, Hussein I, Lehtinen J, Sivelä J, Hyökki S, Nohynek H, Nuorti P, Lyytikäinen O. Qualitative Insights into Vaccine Uptake of Nursing Staff in Long-Term Care Facilities in Finland. Vaccines 2023;11(3):530 View
  30. Pickering G, Mezouar L, Kechemir H, Ebel-Bitoun C. Paracetamol Use in Patients With Osteoarthritis and Lower Back Pain: Infodemiology Study and Observational Analysis of Electronic Medical Record Data. JMIR Public Health and Surveillance 2022;8(10):e37790 View
  31. Jenkins E, Lukose D, Brennan L, Molenaar A, McCaffrey T. Exploring Food Waste Conversations on Social Media: A Sentiment, Emotion, and Topic Analysis of Twitter Data. Sustainability 2023;15(18):13788 View
  32. Dendler L, Morais M, Hargart J, Lourenço J, Vrbos D, Ortega P, Sfugier Tollik K, Alaveras G, Gallani B, Patel M, Broomfield L, Renn O. Participatory versus analytic approaches for understanding risk perceptions: a comparison of three case studies from the field of biotechnology. Journal of Risk Research 2023;26(8):866 View
  33. Yuyang K. Higher Education and Local Innovation Systems: Lessons From Public Attitudes in Shenzhen, China. International Journal of Chinese Education 2023;12(2) View

Books/Policy Documents

  1. Bhattacharyya S, Neenu N. Global Challenges and Strategic Disruptors in Asian Businesses and Economies. View
  2. Dasgupta N, Winokur C, Pierce C. Communicating about Risks and Safe Use of Medicines. View
  3. Bhattacharyya S, Neenu N. Research Anthology on Business Continuity and Navigating Times of Crisis. View